Remdesivir Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for IV & Injection
Available Strengths: Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)
Reference Brands: Veklury® (EU & US)
Category:
Anti Covid Medicines
Remdesivir (Veklury) is an FDA and EMA-approved antiviral used in hospitalized COVID-19 patients. Available as a 100 mg powder or injection solution, it's manufactured by Gilead Sciences. PharmaB2B platforms connect buyers with certified Remdesivir suppliers and distributors in the US and EU, offering compliant sourcing, global shipping, and competitive pricing for hospitals and government tenders.
Remdesivir is available in Lyophilized powder for IV & Injection
and strengths such as Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Remdesivir is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Remdesivir can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Remdesivir (Veklury) is a broad-spectrum antiviral approved in the EU and US for the treatment of hospitalized COVID-19 patients. Manufactured by Gilead Sciences, Remdesivir is available as a 100 mg lyophilized powder and 100 mg/20 mL injection solution. As a key product in critical care, it is in demand across hospitals, distributors, and government tenders. Pharmab2B platforms connect verified Remdesivir suppliers, manufacturers, and wholesalers for compliant sourcing. Ensure regulatory-approved procurement in Europe and the United States through trusted B2B pharmaceutical networks offering competitive pricing, supply reliability, and global shipping.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing